HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenhua Zhou Selected Research

Heroin Dependence (Heroin Abuse)

11/2021Association between GABA receptor delta subunit gene polymorphisms and heroin addiction.
1/2021Association study of genetic polymorphisms in GABRD with treatment response and dose in methadone maintenance treatment.
1/2021Increased Expression of Plasma miRNA-320a and let-7b-5p in Heroin-Dependent Patients and Its Clinical Significance.
11/2020Increased expression of plasma hsa-miR-181a in male patients with heroin addiction use disorder.
1/2020Huperzine A inhibits heroin-seeking behaviors induced by cue or heroin priming in rats.
1/2019Cognitive enhancers as a treatment for heroin relapse and addiction.
8/2017N-acetylaspartylglutamate Inhibits Heroin Self-Administration and Heroin-Seeking Behaviors Induced by Cue or Priming in Rats.
9/2016Association between genetic variations of NMDA receptor NR3 subfamily genes and heroin addiction in male Han Chinese.
9/2016H4K5 histone acetylation of BRG1 is associated with heroin administration rather than addiction.
9/2014The phosphodiesterase-4 inhibitor rolipram attenuates heroin-seeking behavior induced by cues or heroin priming in rats.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenhua Zhou Research Topics

Disease

18Heroin Dependence (Heroin Abuse)
11/2021 - 04/2011
11Neoplasms (Cancer)
02/2022 - 01/2016
9Substance-Related Disorders (Drug Abuse)
11/2021 - 05/2010
7Thrombotic Thrombocytopenic Purpura
01/2009 - 04/2004
5Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2013
4Cognitive Dysfunction
01/2022 - 07/2015
3Chronic Kidney Failure (Chronic Renal Failure)
12/2022 - 07/2017
3Brain Diseases (Brain Disorder)
01/2021 - 09/2016
3Pain (Aches)
01/2020 - 06/2007
2Schizophrenia (Dementia Praecox)
01/2021 - 07/2012
2Neuroinflammatory Diseases
01/2019 - 08/2013
2Inflammation (Inflammations)
11/2018 - 01/2015
2IGA Glomerulonephritis (IGA Nephropathy)
09/2017 - 07/2017
2Type 2 Diabetes Mellitus (MODY)
04/2016 - 11/2011
2Mental Disorders (Mental Disorder)
01/2016 - 12/2013
2Diabetic Nephropathies (Diabetic Nephropathy)
02/2015 - 08/2012
2Memory Disorders (Memory Loss)
08/2014 - 08/2013
2Opioid-Related Disorders (Opiate Addiction)
12/2013 - 05/2005
1Diabetes Mellitus
05/2022
1Cardiovascular Diseases (Cardiovascular Disease)
02/2022
1COVID-19
06/2021
1Papillomavirus Infections
06/2021
1Squamous Cell Carcinoma of Head and Neck
06/2021
1Bipolar Disorder (Manic Depressive Psychosis)
01/2021
1Amphetamine-Related Disorders (Addiction, Amphetamine)
01/2021
1Multiple Sclerosis
01/2021
1Peritonitis
12/2020
1Gram-Negative Bacterial Infections
12/2020
1Dyslipidemias (Dyslipidemia)
08/2020
1Hypertensive Crisis
01/2020
1Mononeuropathies (Mononeuritis Multiplex)
01/2020
1Infections
01/2020
1Hyperalgesia
01/2020
1Zika Virus Infection
01/2020
1Neuralgia (Stump Neuralgia)
01/2020
1Depressive Disorder (Melancholia)
01/2019
1Necrosis
01/2019

Drug/Important Bio-Agent (IBA)

13Heroin (Diamorphine)IBA
11/2021 - 04/2011
6Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2012
5Pharmaceutical PreparationsIBA
11/2021 - 01/2011
4MicroRNAs (MicroRNA)IBA
01/2021 - 10/2015
4Phosphorus (Red Phosphorus)IBA
01/2020 - 01/2018
4AntibodiesIBA
01/2020 - 12/2005
4thiamine triphosphorate (TTP)IBA
03/2007 - 04/2004
3CytokinesIBA
01/2019 - 01/2018
3Amyloid (Amyloid Fibrils)IBA
01/2018 - 08/2013
3Metalloproteases (Metalloproteinases)IBA
01/2009 - 04/2004
2GABA Receptors (GABA Receptor)IBA
11/2021 - 01/2021
22-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA
01/2021 - 01/2021
2LipidsIBA
08/2020 - 04/2016
2Immunoglobulin G (IgG)IBA
01/2020 - 05/2006
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 06/2016
2LipopolysaccharidesIBA
01/2019 - 11/2018
2Fast Green FCFIBA
01/2019 - 01/2018
2Peptides (Polypeptides)IBA
12/2018 - 08/2013
2Opioid Receptors (Opioid Receptor)IBA
09/2018 - 08/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
07/2017 - 10/2008
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2016 - 11/2011
2Scopolamine (Hyoscine)FDA Link
01/2016 - 12/2013
2Amyloid beta-PeptidesIBA
08/2014 - 08/2013
2Risperidone (Risperdal Consta)FDA LinkGeneric
08/2013 - 07/2012
2von Willebrand FactorIBA
08/2007 - 04/2004
2EnzymesIBA
05/2006 - 04/2004
1AlbuminsIBA
05/2022
1Biological ProductsIBA
02/2022
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2022
1InflammasomesIBA
01/2022
1Aminobutyrates (Aminobutyric Acid)IBA
11/2021
1NitrogenIBA
10/2021
1Oxygen (Dioxygen)IBA
10/2021
1Recombinases (Recombinase)IBA
06/2021
1DNA (Deoxyribonucleic Acid)IBA
06/2021
1ParaffinIBA
06/2021
1Formaldehyde (Formol)FDA Link
06/2021
1Corticotropin-Releasing HormoneIBA
01/2021
1Methadone (Dolophine)FDA LinkGeneric
01/2021
1AmphetaminesIBA
01/2021
1Propofol (Diprivan)FDA LinkGeneric
01/2021
1Hemoglobins (Hemoglobin)IBA
12/2020
1Circulating Tumor DNAIBA
10/2020
1Monoamine Oxidase (MAO)IBA
01/2020
1Serotonin (5 Hydroxytryptamine)IBA
01/2020
1N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
01/2020
1AntidotesIBA
01/2020
15-Hydroxytryptophan (5 Hydroxytryptophan)IBA
01/2020
15-HT1A Serotonin ReceptorIBA
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1chrysinIBA
01/2020
1FlavonoidsIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Ethylene Glycol (Monoethylene Glycol)IBA
08/2019
1Phosphates (Orthophosphate)IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Interleukin-1 (Interleukin 1)IBA
01/2019
1AnionsIBA
01/2019

Therapy/Procedure

12Therapeutics
01/2021 - 05/2006
3Peritoneal Dialysis
12/2022 - 12/2020
2Radiotherapy
12/2018 - 01/2018
1Renal Dialysis (Hemodialysis)
05/2022
1Aftercare (After-Treatment)
01/2020